Sponsored content is premium paid-for content produced by our Content Studio on behalf of commercial clients. Our newsroom or other editorial departments are not involved in the production of sponsored content.

Gilead Sciences: building a sustainable future

Anywhere, any size, any orientation

David Cadogan, Gilead Sciences, VP of Manufacturing Operations
David Cadogan, Gilead Sciences, VP of Manufacturing Operations

Gilead Sciences is a leading biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need.

Since first establishing its operations in Ireland in 1999, Gilead has invested more than €225m and considerably expanded its presence in the country.

Today, the company directly employs just under 400 employees and provides indirect employment for another 250 workers in its three Irish sites that are involved in manufacturing, distribution and financial services activities.

“Gilead is a remarkable company that is driven by a common commitment to making groundbreaking medical discoveries to help patients and save lives and every single employee has a role to play to make it happen,” said David Cadogan, vice president of manufacturing operations.

Most of these medicines are manufactured in the Carrigtwohill plant for supply to over 90 countries.

The Carrigtwohill facility is the company’s manufacturing and packaging centre, and its nearby operation in Little Island deals with financial services.

Gilead Sciences has developed a worldwide sustainability strategy built on the initiatives to reduce the impact associated with its supply chain, and the manufacturing and distribution of its products
Gilead Sciences has developed a worldwide sustainability strategy built on the initiatives to reduce the impact associated with its supply chain, and the manufacturing and distribution of its products

Dublin is the distribution centre for Europe, the Middle East and Asia.

Gilead also recognises that its responsibility goes beyond bringing innovative medicines to patients.

“We strive to invest in our people and our environment, and forge partnerships to create a sustainable future for the communities we serve.”

One of the ways Gilead is working to achieve a more sustainable future is to commit to the socially and environmentally responsible production of its medicines.

“Through the years, the company has developed a worldwide sustainability strategy built on the initiatives to reduce the impact associated with our supply chain, the manufacturing and distribution of our products, and the design, construction and operations of our worldwide corporate facilities.

"We have established a goal to reduce our global scope 1 and 2 greenhouse gas emissions by 25% by 2025, compared with a 2016 baseline,” said Mr Cadogan.

Gilead Sciences: building a sustainable future

The Cork manufacturing facility is at the forefront of these initiatives.

It marked its sixth consecutive year as a zero-waste facility, running on 100% renewable energy.

“The newly created green team comprising energy champions from different departments aims to encourage individual and collective commitment to making a difference within Gilead to reduce its global carbon footprint,” he said.

The individual commitment of its employees is crucial to everything Gilead does as the staff numbers have increased over the years.

The company was fortunate to have a fantastic skillset in Cork and Ireland and continues to invest in science-based careers with an interest in encouraging diversity in science, technology, engineering and math fields.

Gilead was a main sponsor of the recent Southwest event in Cork, a collaboration which is hosted between industry and academia specifically aimed at providing post-primary students and their supporters (parents, teachers, guidance counsellors), as well as career changers and job seekers, with the opportunity to explore the benefits a career in those subjects can offer.

Gilead Sciences: building a sustainable future

“Gilead offers employees a unique opportunity to combine professional advancement and continual learning with the ability to impact our local communities and people around the world,” said Mr Cadogan.

Supporting our communities is an important part of our role as a company.

Globally, Gilead supports numerous access programmes as well as public health ambitions such as the elimination of hepatitis C by 2030 and ending HIV transmission by 2030.

“Supporting communities is also core to the Irish operations. Our employees participate in organised volunteer activities through which we look to provide support to many worthy causes and initiatives.”

Gilead remains fully committed to Ireland and will continue to invest in its operations to build a sustainable future for the employees, environment and communities we serve while pursuing our core mission of bringing innovative treatments to address unmet medical needs.

gilead.com

More on this topic

Allstate sees potential for Ireland as global business hubAllstate sees potential for Ireland as global business hub

Automation solutions for MedTech sectorAutomation solutions for MedTech sector

Jameson continues on phenomenal conquest of United StatesJameson continues on phenomenal conquest of United States

Edwards Lifesciences developing innovative treatmentsEdwards Lifesciences developing innovative treatments


Lifestyle

When Marisa Murphy went to play as a teenager on Dinish Island, she could still see the flowers growing among the ruins in her grandmother’Islands of Ireland: Barely inhabitated Dinish became an industrial zone

MAC make-up artist Lucy Bridge shares her tips backstage at Roland Mouret.How to create the perfect matte red lip, according to a backstage beauty expert

New trends include chunky heeled boots, silver belts and lots of plaid from the British designer.Victoria Beckham got ‘rebellious’ for her new collection – as David and family watched on

When horses were shown photographs of angry human faces, their hearts speeded up.Jackass penguin talk is similar to humans